{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:31:54Z","timestamp":1791297114146,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Brain Research"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.molbrainres.2004.09.017","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T18:20:25Z","timestamp":1103134825000},"page":"57-66","source":"Crossref","is-referenced-by-count":316,"title":["The MPTP model of Parkinson's disease"],"prefix":"10.1016","volume":"134","author":[{"given":"Richard Jay","family":"Smeyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernice","family":"Jackson-Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molbrainres.2004.09.017_bib1","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1073\/pnas.95.13.7659","article-title":"Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)","volume":"95","author":"Ara","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","article-title":"Mitochondria, oxidative damage, and inflammation in Parkinson's disease","volume":"991","author":"Beal","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0278-5846(93)90038-T","article-title":"Iron, melanin and dopamine interaction: relevance to Parkinson's disease","volume":"17","author":"Ben-Shachar","year":"1993","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/exnr.1998.6995","article-title":"Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter","volume":"155","author":"Bezard","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0306-4522(94)00370-K","article-title":"A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle","volume":"64","author":"Brecknell","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01244987","article-title":"Astrocytes as a primary locus for the conversion MPTP into MPP+","volume":"76","author":"Brooks","year":"1989","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01192-5","article-title":"Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss","volume":"823","author":"Brooks","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.nrl.0000117822.90759.83","article-title":"Recent advances in research on Parkinson disease: synuclein and parkin","volume":"10","author":"Burke","year":"2004","journal-title":"Neurologist"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib10","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJM198505303122203","article-title":"The clinical syndrome of striatal dopamine deficiency; parkinsonism induced by MPTP","volume":"312","author":"Burns","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0169-328X(93)90187-T","article-title":"Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain","volume":"18","author":"Cerruti","year":"1993","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(98)00554-0","article-title":"Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL\/6 mice","volume":"252","author":"Cheng","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1046\/j.1471-4159.2001.00096.x","article-title":"Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism","volume":"76","author":"Chun","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib14","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1471-4159.1992.tb09789.x","article-title":"Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement","volume":"58","author":"Cleeter","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0169-328X(02)00659-9","article-title":"Identification of a single QTL, Mptp1, for susceptibility to MPTP-induced substantia nigra pars compacta neuron loss in mice","volume":"110","author":"Cook","year":"2003","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.3080808","article-title":"Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin","volume":"231","author":"D'Amato","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib18","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib19","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/00001756-199807130-00039","article-title":"GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice","volume":"9","author":"Date","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1476-5381.1993.tb13584.x","article-title":"Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity","volume":"109","author":"Del Zompo","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib21","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1212\/WNL.45.12.2143","article-title":"Prevalence of Parkinson's disease in the elderly: the Rotterdam Study","volume":"45","author":"de Rijk","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway","volume":"175","author":"Deumens","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1474-4422(03)00501-5","article-title":"The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?","volume":"2","author":"Di Monte","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-291X(86)91210-6","article-title":"Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP+) cytotoxicity","volume":"137","author":"Di Monte","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/glia.440050108","article-title":"Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes","volume":"5","author":"Di Monte","year":"1992","journal-title":"Glia"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib26","first-page":"697","article-title":"Astrocytes as the site for bioactivation of neurotoxins","volume":"17","author":"Di Monte","year":"1996","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1523\/JNEUROSCI.19-02-00562.1999","article-title":"Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione","volume":"19","author":"Dringen","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0891-5849(98)00050-1","article-title":"Astrocyte-enhanced neuronal survival is mediated by scavenging of extracellular reactive oxygen species","volume":"25","author":"Drukarch","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/paa.1999.111.5.438","article-title":"Heme oxygenase: recent advances in understanding its regulation and role","volume":"111","author":"Elbirt","year":"1999","journal-title":"Proc. Assoc. Am. Physicians"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib30","series-title":"Merritt's Neurology","first-page":"679","article-title":"Parkinsonism","author":"Fahn","year":"2000"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0306-4522(78)90119-7","article-title":"The cells of origin of nigrotectal, nigrothalamic and nigrostriatal projections in the rat","volume":"3","author":"Faull","year":"1978","journal-title":"Neuroscience"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib32","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1460-9568.2000.00044.x","article-title":"MPTP selectively induces heme oxygenase-1 expression in striatal astrocytes","volume":"12","author":"Fernandez-Gonzales","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0006-8993(00)02999-1","article-title":"Time-course and dose\u2013response study on the effects of chronic l-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity","volume":"887","author":"Fornai","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0079-6123(08)61770-7","article-title":"Astrocytes and Parkinson's disease","volume":"94","author":"Forno","year":"1992","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib35","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1073\/pnas.91.11.5104","article-title":"Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat","volume":"91","author":"Frim","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib36","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1471-4159.1997.69031322.x","article-title":"Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter","volume":"69","author":"Gainetdinov","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib37","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1046\/j.1471-4159.1998.70051973.x","article-title":"Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice","volume":"70","author":"Gainetdinov","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s004150170066","article-title":"Genetics of Parkinson's disease","volume":"248","author":"Gasser","year":"2001","journal-title":"J. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ana.410260403","article-title":"Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization","volume":"26","author":"German","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib41","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0","article-title":"A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease","volume":"59","author":"Giasson","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3940(99)00148-2","article-title":"Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death","volume":"263","author":"Gong","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib43","first-page":"633","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib44","series-title":"The Neostriatum","first-page":"37","article-title":"Extrinsic connections of the neostriatum","author":"Grofova","year":"1979"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib45","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1471-4159.1991.tb03776.x","article-title":"Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mouse","volume":"57","author":"Hadjiconstantinou","year":"1991","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0006-8993(99)01273-1","article-title":"Differential strain susceptibility following 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) administration acts in an autosomal dominant fashion: quantitative analysis in seven strains of Mus musculus","volume":"828","author":"Hamre","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib47","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/000992289403300802","article-title":"Bilirubin in the brain. distribution and effects on neurophysiological and neurochemical processes","volume":"33","author":"Hansen","year":"1994","journal-title":"Clin. Pediatr. (Phila)"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib48","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.64020919.x","article-title":"Enzymatic oxidation of dopamine: the role of prostaglandin H synthase","volume":"64","author":"Hastings","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0378-4274(96)03825-8","article-title":"Mechanism for mouse strain differences in the protective effect of sudan III against the in vivo genotoxicity of 7, 12-dimethylbenz[a]anthracene","volume":"89","author":"Hatakeyama","year":"1996","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib50","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1046\/j.1471-4159.1997.68052216.x","article-title":"1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) decreases glutamate uptake in cultured astrocytes","volume":"68","author":"Hazell","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-3806(02)00610-7","article-title":"Effects of ethanol on neurotrophic factors, apoptosis-related proteins, endogenous antioxidants, and reactive oxygen species in neonatal striatum: relationship to periods of vulnerability","volume":"140","author":"Heaton","year":"2003","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF02251226","article-title":"Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease","volume":"10","author":"Higuchi","year":"1995","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib53","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1471-4159.2002.01013.x","article-title":"Effects of dopamine on the glutathione metabolism of cultured astroglial cells: implications for Parkinson's disease","volume":"82","author":"Hirrlinger","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib54","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/ana.410440717","article-title":"Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration?","volume":"44","author":"Hirsch","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-7091-0643-3_6","article-title":"Animal models of Parkinson's disease in rodents induced by toxins: an update","author":"Hirsch","year":"2003","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000008008","article-title":"No mutation of G209A in the alpha-synuclein gene in sporadic Parkinson's disease among Taiwan Chinese","volume":"41","author":"Hu","year":"1999","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib57","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","article-title":"FcepsilonRII\/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells","volume":"19","author":"Hunot","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1471-4159.2003.01566.x","article-title":"Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes","volume":"84","author":"Inazu","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-5793(95)00307-U","article-title":"Peroxynitrite-mediated oxidative protein modifications","volume":"364","author":"Ischiropoulos","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib60","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib61","first-page":"4525","article-title":"Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients","volume":"12","author":"Jan","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002512-199914020-00004","article-title":"The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease","volume":"14","author":"Jellinger","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib63","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1353-8020(02)00115-3","article-title":"The contribution of the MPTP-treated primate model to the development of new treatment strategies for Parkinson's disease","volume":"9","author":"Jenner","year":"2003","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib64","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1073\/pnas.84.10.3521","article-title":"Correlation of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity with blood\u2013brain barrier monoamine oxidase activity","volume":"84","author":"Kalaria","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib65","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0024-3205(99)00458-0","article-title":"Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?","volume":"65","author":"Kienzl","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib66","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(95)01513-2","article-title":"NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals","volume":"713","author":"Kirschner","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/syn.890150107","article-title":"Dopamine transporter mutants selectively enhance MPP+ transport","volume":"15","author":"Kitayama","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib68","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/mcne.2000.0914","article-title":"Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2","volume":"16","author":"Knott","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib69","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.1992.tb24527.x","article-title":"Features of the dopaminergic neurotoxin MPTP","volume":"648","author":"Kopin","year":"1992","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.ne.11.030188.000501","article-title":"MPTP toxicity: implications for research in Parkinson's disease","volume":"11","author":"Kopin","year":"1988","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib71","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1523\/JNEUROSCI.19-23-10289.1999","article-title":"Peroxynitrite inactivation of tyrosine hydroxylase: mediation by sulfhydryl oxidation, not tyrosine nitration","volume":"19","author":"Kuhn","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib72","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/BF01291883","article-title":"Excessive iron accumulation in the brain: a possible potential risk of neurodegeneration in Parkinson's disease","volume":"104","author":"Lan","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0076-6879(96)68007-0","article-title":"Diffusion of free nitric oxide","volume":"268","author":"Lancaster","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib74","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1126\/science.8091226","article-title":"Genetic dissection of complex traits","volume":"265","author":"Lander","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/j.2326-1951.1985.tb02766.x","article-title":"The case of the tainted heroin","volume":"25","author":"Langston","year":"1985","journal-title":"Sciences"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib76","series-title":"The Case of the Frozen Addicts","author":"Langston","year":"1996"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib77","first-page":"189","article-title":"Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)","volume":"12","author":"Lau","year":"1991","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib78","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1046\/j.1471-4159.1999.0732546.x","article-title":"Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss","volume":"73","author":"LaVoie","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib79","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/mds.870120523","article-title":"Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease","volume":"12","author":"Le Couteur","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib80","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0014-4886(83)90268-6","article-title":"Effects of neonatal destruction of the medial forebrain bundle in the cat: long-term neurochemical, locomotor, and regulatory deficits","volume":"81","author":"Levine","year":"1983","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib81","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib82","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(92)90425-C","article-title":"A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter","volume":"70","author":"Liu","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib83","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/syn.10090","article-title":"Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: a PET study","volume":"45","author":"Ma","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib84","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev.pharmtox.37.1.517","article-title":"The heme oxygenase system: a regulator of second messenger gases","volume":"37","author":"Maines","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib85","first-page":"573","article-title":"The heme oxygenase system and its functions in the brain","volume":"46","author":"Maines","year":"2000","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"issue":"Suppl. 3","key":"10.1016\/j.molbrainres.2004.09.017_bib86","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1468-1331.9.s3.2.x","article-title":"Do dopamine agonists or levodopa modify Parkinson's disease progression?","volume":"9","author":"Marek","year":"2002","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib87","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1471-4159.1992.tb11336.x","article-title":"Accumulation of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in cultured cerebellar astrocytes","volume":"58","author":"Marini","year":"1992","journal-title":"J. Neurochem."},{"issue":"Suppl. 2","key":"10.1016\/j.molbrainres.2004.09.017_bib88","first-page":"S1","article-title":"Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions","volume":"12","author":"McGeer","year":"1998","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib89","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1046\/j.1471-4159.1999.0732469.x","article-title":"Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic\/ventral mesencephalic co-cultures","volume":"73","author":"McNaught","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib90","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0006-2952(96)00091-3","article-title":"Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) on mitochondrial respiration","volume":"51","author":"McNaught","year":"1996","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.molbrainres.2004.09.017_bib91","doi-asserted-by":"crossref","first-page":"II135","DOI":"10.1007\/PL00022914","article-title":"Levodopa\u2014an exotoxin or a therapeutic drug?","volume":"247","author":"Melamed","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib92","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/exnr.1998.7008","article-title":"Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease","volume":"156","author":"Miller","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib93","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0165-6147(99)01379-6","article-title":"Dopamine transporters and neuronal injury","volume":"20","author":"Miller","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib94","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1046\/j.1471-4159.1994.62051906.x","article-title":"Resistance of golden hamster to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: relationship with low levels of regional monoamine oxidase B","volume":"62","author":"Mitra","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib95","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-510X(88)90010-X","article-title":"Studies on the toxicity of 1-methyl-4-phenylpyridinium ion (MPP+) against mitochondria of mouse brain","volume":"86","author":"Mizuno","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0022-510X(88)90010-X","article-title":"Studies on the toxicity of 1-methyl-4-phenylpyridinium ion (MPP+) against mitochondria of mouse brain","volume":"86","author":"Mizuno","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib97","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(03)00185-X","article-title":"Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease","volume":"341","author":"Muller","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib98","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00702-003-0021-y","article-title":"Cerebral alterations in a MPTP-mouse model of Parkinson's disease\u2014an immunocytochemical study","volume":"110","author":"Muramatsu","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib99","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/exnr.1994.1058","article-title":"Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in C57\/bl and CD-1 mice","volume":"126","author":"Muthane","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib100","first-page":"277","article-title":"Changes in cytokines and neurotrophins in Parkinson's disease","author":"Nagatsu","year":"2000","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib101","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(01)02866-9","article-title":"GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons","volume":"916","author":"Nakajima","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib102","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib103","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/0024-3205(87)90299-2","article-title":"MPTP, MPP+ and mitochondrial function","volume":"40","author":"Nicklas","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib104","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.1139","article-title":"Rate of progression in Parkinson's disease: a 6-[18F]fluoro-l-dopa PET study","volume":"16","author":"Nurmi","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib105","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1517\/13543784.8.10.1521","article-title":"COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration","volume":"8","author":"O'Banion","year":"1999","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib106","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/0028-3908(87)90009-8","article-title":"Effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) on dopamine synthesis and release in the rabbit retina in vitro","volume":"26","author":"Ofori","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib107","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0014-4886(90)90134-E","article-title":"Excitotoxicity of l-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases","volume":"108","author":"Olney","year":"1990","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib108","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/glia.440110107","article-title":"FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells","volume":"11","author":"Otto","year":"1994","journal-title":"Glia"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib109","series-title":"An Essay on Shaking Palsy","author":"Parkinson","year":"1817"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/089198879801100207","article-title":"Genetic epidemiology of Parkinson's disease","volume":"11","author":"Payami","year":"1998","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib111","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0361-9230(01)00580-9","article-title":"Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death","volume":"56","author":"Petersen","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib112","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib113","doi-asserted-by":"crossref","first-page":"10919","DOI":"10.1073\/pnas.94.20.10919","article-title":"Heme oxygenase 1 is required for mammalian iron reutilization","volume":"94","author":"Poss","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib114","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","article-title":"The 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease","volume":"991","author":"Przedborski","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib115","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1523\/JNEUROSCI.12-05-01658.1992","article-title":"Transgenic mice with increased Cu\/Zn\u2013superoxide dismutase activity are resistant to N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity","volume":"12","author":"Przedborski","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib116","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1073\/pnas.93.10.4565","article-title":"Role of neuronal nitric oxide in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity","volume":"93","author":"Przedborski","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib117","first-page":"135","article-title":"The parkinsonian toxin MPTP: action and mechanism","volume":"16","author":"Przedborski","year":"2000","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib118","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1471-4159.2001.00174.x","article-title":"Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib119","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0891-5849(02)01111-5","article-title":"Peroxynitrite reactions and formation in mitochondria","volume":"33","author":"Radi","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib120","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/S0021-9258(19)57434-8","article-title":"Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine, by mitochondria","volume":"261","author":"Ramsay","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib121","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0024-3205(86)90037-8","article-title":"Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP","volume":"39","author":"Ramsay","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib122","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0304-3940(87)90543-X","article-title":"Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+","volume":"75","author":"Ransom","year":"1987","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib123","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/0024-3205(88)90189-0","article-title":"Strain differences in systemic 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood\u2013brain barrier","volume":"42","author":"Riachi","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib124","first-page":"443","article-title":"On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver","volume":"244","author":"Riachi","year":"1988","journal-title":"JPET"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0006-8993(90)91788-I","article-title":"Effects of internal carotid administration of MPTP on rat brain and blood\u2013brain barrier","volume":"533","author":"Riachi","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib126","first-page":"858","article-title":"MPP+-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis","volume":"245","author":"Rollema","year":"1988","journal-title":"JPET"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib127","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1460-9568.1996.tb01294.x","article-title":"The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia","volume":"8","author":"Russ","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib128","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/exnr.1993.1207","article-title":"Regional and cell-specific expression of GDNF in rat brain","volume":"124","author":"Schaar","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib129","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1006\/exnr.1994.1218","article-title":"Multiple astrocyte transcripts encode nigral trophic factors in rat and human","volume":"130","author":"Schaar","year":"1994","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib130","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.STR.31.9.2212","article-title":"Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates bax and bcl-2 expression after temporary focal cerebral ischemia","volume":"31","author":"Schabitz","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib131","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF03033339","article-title":"Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases","volume":"1","author":"Schipper","year":"1999","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib132","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/exnr.1997.6752","article-title":"Neural heme oxygenase-1 expression in idiopathic Parkinson's disease","volume":"150","author":"Schipper","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib133","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/exnr.1998.6854","article-title":"Astrocyte mitochondria: a substrate for iron deposition in the aging rat substantia nigra","volume":"152","author":"Schipper","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib134","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0306-4522(03)00036-8","article-title":"Role of alpha-synuclein in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in mice","volume":"118","author":"Schluter","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-2999(84)90485-0","article-title":"In vitro release of tritiated monoamines from rat CNS tissue by the neurotoxic compound 1-methyl-phenyl-tetrahydropyridine","volume":"103","author":"Schmidt","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib136","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0169-328X(99)00231-4","article-title":"Regulation of heme oxygenase-1 expression by dopamine in cultured C6 glioma and primary astrocytes","volume":"73","author":"Schmidt","year":"1999","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib137","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0301-0082(96)00040-8","article-title":"The unilateral 6-hydroxydopamine lesion model in behavioral brain research. analysis of functional deficits, recovery and treatments","volume":"50","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib138","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s100480050083","article-title":"The alpha-synuclein gene is not a major risk factor in familial Parkinson disease","volume":"2","author":"Scott","year":"1999","journal-title":"Neurogenetics"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib139","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2174\/0929867033456882","article-title":"Coenzyme Q10 in neurodegenerative diseases","volume":"10","author":"Shults","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib140","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1046\/j.1471-4159.1998.70051859.x","article-title":"Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway","volume":"70","author":"Skaper","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib141","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1016\/S0021-9258(17)36277-4","article-title":"Hydroxyl radical attack on dopamine","volume":"260","author":"Slivka","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib142","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/glia.1042","article-title":"Strain-dependent susceptibility to MPTP and MPP+-induced Parkinsonism is determined by glia","volume":"74","author":"Smeyne","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib143","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0278-5846(88)90054-1","article-title":"Neurotoxic effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice","volume":"12","author":"Sonsalla","year":"1988","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib144","doi-asserted-by":"crossref","first-page":"18344","DOI":"10.1074\/jbc.M000206200","article-title":"Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies","volume":"275","author":"Souza","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1471-4159.1992.tb08880.x","article-title":"Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system","volume":"59","author":"Spina","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib146","doi-asserted-by":"crossref","first-page":"13972","DOI":"10.1073\/pnas.242594999","article-title":"Etiology of Parkinson's disease: genetics and environment revisited","volume":"99","author":"Steece-Collier","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Suppl. 2","key":"10.1016\/j.molbrainres.2004.09.017_bib147","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1017\/S0317167100000032","article-title":"Etiology of Parkinson's disease","volume":"26","author":"Stoessl","year":"1999","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib148","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0006-8993(87)90986-3","article-title":"Studies on the effect of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) on central catacholamine neurons in C57Bl\/6 mice. comparison with three other strains of mice","volume":"405","author":"Sundstrom","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib149","first-page":"215","article-title":"Effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration","volume":"53","author":"Suzuki","year":"1990","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib150","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1073\/pnas.94.18.9938","article-title":"VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity","volume":"94","author":"Takahashi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib151","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib152","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.10332","article-title":"Pathogenic role of glial cells in Parkinson's disease","volume":"18","author":"Teismann","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib153","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.1523\/JNEUROSCI.20-24-09207.2000","article-title":"The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease","volume":"20","author":"Thiruchelvam","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib154","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1227\/00006123-199510000-00018","article-title":"Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in monkeys","volume":"37","author":"Tsukahara","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1016\/j.molbrainres.2004.09.017_bib155","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1046\/j.1471-4159.2000.0741434.x","article-title":"Astrocytes provide cysteine to neurons by releasing glutathione","volume":"74","author":"Wang","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib156","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson's disease with ropinirole vs. levodopa: the REAL-PET study","volume":"54","author":"Whone","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib157","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1749-6632.2003.tb07477.x","article-title":"Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder","volume":"991","author":"Wichmann","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib158","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib159","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib160","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/1029842021000045507","article-title":"Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of iron","volume":"4","author":"Youdim","year":"2002","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.molbrainres.2004.09.017_bib161","series-title":"Parkinson's Disease and Movement Disorders","first-page":"1","article-title":"Biochemical and functional organization of the basal ganglia","author":"Young","year":"1993"}],"container-title":["Molecular Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169328X04004553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169328X04004553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T22:34:28Z","timestamp":1682894068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169328X04004553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0169328X04004553"],"URL":"https:\/\/doi.org\/10.1016\/j.molbrainres.2004.09.017","relation":{},"ISSN":["0169-328X"],"issn-type":[{"value":"0169-328X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}